These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26239993)

  • 1. Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness.
    Kay K; Hodel EM; Hastings IM
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6419-27. PubMed ID: 26239993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania.
    Mosha D; Guidi M; Mwingira F; Abdulla S; Mercier T; Decosterd LA; Csajka C; Genton B
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4583-92. PubMed ID: 24867986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?
    Hastings IM; Kay K; Hodel EM
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6428-36. PubMed ID: 26239987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.
    Kloprogge F; Workman L; Borrmann S; Tékété M; Lefèvre G; Hamed K; Piola P; Ursing J; Kofoed PE; Mårtensson A; Ngasala B; Björkman A; Ashton M; Friberg Hietala S; Aweeka F; Parikh S; Mwai L; Davis TME; Karunajeewa H; Salman S; Checchi F; Fogg C; Newton PN; Mayxay M; Deloron P; Faucher JF; Nosten F; Ashley EA; McGready R; van Vugt M; Proux S; Price RN; Karbwang J; Ezzet F; Bakshi R; Stepniewska K; White NJ; Guerin PJ; Barnes KI; Tarning J
    PLoS Med; 2018 Jun; 15(6):e1002579. PubMed ID: 29894518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Lefèvre G; Looareesuwan S; Treeprasertsuk S; Krudsood S; Silachamroon U; Gathmann I; Mull R; Bakshi R
    Am J Trop Med Hyg; 2001; 64(5-6):247-56. PubMed ID: 11463111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development.
    Zaloumis S; Humberstone A; Charman SA; Price RN; Moehrle J; Gamo-Benito J; McCaw J; Jamsen KM; Smith K; Simpson JA
    Malar J; 2012 Aug; 11():303. PubMed ID: 22931058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemether-lumefantrine: an option for malaria.
    Stover KR; King ST; Robinson J
    Ann Pharmacother; 2012 Apr; 46(4):567-77. PubMed ID: 22496476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Split dosing of artemisinins does not improve antimalarial therapeutic efficacy.
    White NJ; Watson J; Ashley EA
    Sci Rep; 2017 Sep; 7(1):12132. PubMed ID: 28935919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral Therapy.
    Parikh S; Fehintola F; Huang L; Olson A; Adedeji WA; Darin KM; Morse GD; Murphy RL; Taiwo BO; Akinyinka OO; Adewole IF; Aweeka FT; Scarsi KK
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7852-6. PubMed ID: 26392500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.
    Ashley EA; Stepniewska K; Lindegårdh N; McGready R; Annerberg A; Hutagalung R; Singtoroj T; Hla G; Brockman A; Proux S; Wilahphaingern J; Singhasivanon P; White NJ; Nosten F
    Trop Med Int Health; 2007 Feb; 12(2):201-8. PubMed ID: 17300626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coartemether (artemether and lumefantrine): an oral antimalarial drug.
    Wernsdorfer WH
    Expert Rev Anti Infect Ther; 2004 Apr; 2(2):181-96. PubMed ID: 15482185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®).
    Tiono AB; Tinto H; Alao MJ; Meremikwu M; Tshefu A; Ogutu B; Ouedraogo A; Lingani M; Cousin M; Lefèvre G; Jain JP; Duparc S; Hamed K
    Malar J; 2015 Apr; 14():157. PubMed ID: 25886021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar Border.
    Kloprogge F; McGready R; Hanpithakpong W; Blessborn D; Day NP; White NJ; Nosten F; Tarning J
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6375-84. PubMed ID: 26239986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
    White NJ; van Vugt M; Ezzet F
    Clin Pharmacokinet; 1999 Aug; 37(2):105-25. PubMed ID: 10496300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.
    Parikh S; Kajubi R; Huang L; Ssebuliba J; Kiconco S; Gao Q; Li F; Were M; Kakuru A; Achan J; Mwebaza N; Aweeka FT
    Clin Infect Dis; 2016 Aug; 63(3):414-22. PubMed ID: 27143666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
    Gerardin J; Eckhoff P; Wenger EA
    BMC Infect Dis; 2015 Mar; 15():144. PubMed ID: 25887935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia.
    Aponte S; Guerra ÁP; Álvarez-Larrotta C; Bernal SD; Restrepo C; González C; Yasnot MF; Knudson-Ospina A
    Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):71-80. PubMed ID: 28460112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.
    Djimde AA; Makanga M; Kuhen K; Hamed K
    Expert Rev Anti Infect Ther; 2015 Aug; 13(8):1031-45. PubMed ID: 26081265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Enfranze, north-west Ethiopia.
    Getnet G; Fola AA; Alemu A; Getie S; Fuehrer HP; Noedl H
    Malar J; 2015 Jun; 14():258. PubMed ID: 26105035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.